|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prostate specific membrane antigen knockdown impairs the tumorigenicity of LNCaP prostate cancer cells by inhibiting the phosphatidylinositol 3-kinase/Akt signaling pathway显示文摘 | Guo Zhenghui Lai Yiming Du Tao Zhang Yiming Chen Jieqing Bi Liangkuan Lin Tianxin Liu Hao Wang Wei Xu Kewei Jiang Chun Han Jinli Zhang Caixia Dong Wen Huang Jian Huang Hai | 2014 | Chinese Medical Journal2014，，5： | 2 |
| 2 | Homomorphisms between fuzzy information systems 显示文摘 | Wang Changzhong Chen Degang Zhu Liangkuan | 2009 | Applied Mathematics Letters2009，22，： | 1 |
| 3 | Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomy显示文摘 | Kaiwen Li Tianxin Lin Xinxiang Fan Kewei Xu Liangkuan Bi Yu Duan Yu Zhou Min Yu Jielin Li Jian Huang | 2013 | Cancer Treatment Reviews2013，，： | 1 |
| 4 | Exosomes in bladder cancer:novel biomarkers and targets显示文摘Exosomes are nanometer-sized vesicles that contain various types of biologically active components,including proteins,nucleic acids,carbohydrates,and lipids,which vary with the type and physiological state of the cell.In recent years,several studies have showed that exosomes can provide new non-invasive diagnostic and prognostic biomarkers in patients affected by cancers,including bladder cancer(BC),and the lipid bilayer membrane structure makes exosomes as promising delivery vehicles for therapeutic applications.Exosomes have the characteristics of high abundance,high stability,tissue specificity,and wide distribution in body fluids,and are secreted as various types by cells in different states,thereby possessing great potential as biomarkers for BC.Herein,we briefly summarize the functions and roles of exosomes in the occurrence and development of BC and the current progress of research on exosomes in BC,while focusing on potential clinical applications of the diagnosis,treatment,and prognosis of BC. | Hao GENG Qingchen ZHOU Wenhao GUO Ling LU Liangkuan BI Yi WANG Jie MIN Dexin YU Zhaofeng LIANG | 2021 | Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)2021，22，5： | 0 |
| 5 | Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis显示文摘Objective: The interplay between chemokine C-X-C motif ligand 12(CXCL12) and its specific receptors is known to trigger various signaling pathways, contributing to tumor proliferation and metastasis. Consequently,targeting this signaling axis has emerged as a potential strategy in cancer therapy. However, the precise role of CXCL12 in clinical therapy, especially in immunotherapy for bladder cancer(BCa), remains poorly elucidated.Methods: We gathered multiple omics data from public databases to unveil the clinical relevance and tumor immune landscape associated with CXCL12 in BCa patients. Univariate and multivariate Cox regression analyses were employed to assess the independent prognostic significance of CXCL12 expression and formulate a nomogram. The expression of CXCL12 in BCa cell lines and clinical tissue samples was validated using enzymelinked immunosorbent assays(ELISA) and immunohistochemistry(IHC).Results: While transcriptional expression of CXCL12 exhibited a decrease in nearly all tumor tissues, CXCL12 methylation expression was notably increased in BCa tissues. Single-cell RNA analysis highlighted tissue stem cells and endothelial cells as the primary sources expressing CXCL12. Abnormal CXCL12 expression, based on transcriptional and methylation levels, correlated with various clinical characteristics in BCa patients. Functional analysis indicated enrichment of CXCL12 and its co-expression genes in immune regulation and cell adhesion. The immune landscape analysis unveiled a significant association between CXCL12 expression and M2 macrophages(CD163~+ cells) in BCa tissues. Notably, CXCL12 expression emerged as a potential predictor of immunotherapy response and chemotherapy drug sensitivity in BCa patients.Conclusions: Taken together, these findings suggest aberrant production of CXCL12 in BCa tissues,potentially influencing the treatment responses of affected individuals. | Zhouting Tuo Dechao Feng Zhiwei Jiang Liangkuan Bi Chao Yang Qi Wang | 2023 | Chinese Journal of Cancer Research2023，35，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员